Abstract
Fondaparinux, an anticoagulant, is a synthetic and specific inhibitor of activated Factor X (Xa). It binds to antithrombin (AT), increasing the affinity of AT affinity for (Xa). Fondaparinux belongs to the class of newer anticoagulants. Fondaparinux is a synthetic pentasaccharide; it is extensively sulfated and its sequence is derived from the AT binding region of heparin © 2008
| Original language | English |
|---|---|
| Title of host publication | xPharm: The Comprehensive Pharmacology Reference |
| Publisher | Elsevier Inc. |
| Pages | 1-6 |
| Number of pages | 6 |
| ISBN (Print) | 9780080552323 |
| DOIs | |
| State | Published - 2011 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Fondaparinux. / Sindhu, Singh; Silberstein, Peter T.
xPharm: The Comprehensive Pharmacology Reference. Elsevier Inc., 2011. p. 1-6.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Fondaparinux
AU - Sindhu, Singh
AU - Silberstein, Peter T.
PY - 2011
Y1 - 2011
N2 - Fondaparinux, an anticoagulant, is a synthetic and specific inhibitor of activated Factor X (Xa). It binds to antithrombin (AT), increasing the affinity of AT affinity for (Xa). Fondaparinux belongs to the class of newer anticoagulants. Fondaparinux is a synthetic pentasaccharide; it is extensively sulfated and its sequence is derived from the AT binding region of heparin © 2008
AB - Fondaparinux, an anticoagulant, is a synthetic and specific inhibitor of activated Factor X (Xa). It binds to antithrombin (AT), increasing the affinity of AT affinity for (Xa). Fondaparinux belongs to the class of newer anticoagulants. Fondaparinux is a synthetic pentasaccharide; it is extensively sulfated and its sequence is derived from the AT binding region of heparin © 2008
UR - http://www.scopus.com/inward/record.url?scp=84883948992&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883948992&partnerID=8YFLogxK
U2 - 10.1016/B978-008055232-3.64063-2
DO - 10.1016/B978-008055232-3.64063-2
M3 - Chapter
SN - 9780080552323
SP - 1
EP - 6
BT - xPharm: The Comprehensive Pharmacology Reference
PB - Elsevier Inc.
ER -